pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Nephrology · news · pharmadog
← back to Nephrology
News · Nephrology
132
stories
16d
Vertex unfazed by competitive IgAN space as FDA verdict looms
biospace
17d
STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
stat
17d
Amgen hit with cybersecurity breach, patient data affected
biospace
20d
Novo setback casts doubt on a new way to treat heart disease
biopharma dive
20d
Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
biospace
20d
STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
stat
21d
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
fiercebiotech
22d
Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption
stat
22d
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
22d
Biogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectations
biospace
22d
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
24d
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
27d
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
biospace
29d
FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
fda press
29d
Crystalys nets $130M more to push gout drug through late-stage tests
biopharma dive
Jul 20, 26
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
biopharma dive
Jul 20, 26
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
biospace
Jul 20, 26
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial
fiercebiotech
Jul 18, 26
Opinion: Beware the unintended consequences of testosterone screening for military servicemembers
stat
Jul 18, 26
Opinion: STAT readers on the value of primary care, obesity as a disease, and more
stat
Jul 17, 26
Jasper gets a lifeline in merger with immune drugmaker Kira
biopharma dive
Jul 17, 26
Dimerix buys a kidney injury drug; Arpeggio appears to be winding down
endpoints
Jul 17, 26
Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador
fiercebiotech
Jul 17, 26
STAT+: MDCalc is scoring the clinical calculators used by millions of doctors
stat
Jul 17, 26
Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal
fiercebiotech
Jul 16, 26
Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical experts
stat
Jul 15, 26
Deaths from coronary artery disease have fallen, but more progress is within reach
stat
Jul 15, 26
Nava Therapeutics emerges with $89M for lipid nanoparticles
endpoints
Jul 14, 26
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
Jul 13, 26
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
stat
← prev
page 2 of 5
next →
